
Overview
Background
Professor Stephen Mahler is a Senior Group Leader at the Australian Institute for Bioengineering and Nanotechnology and Director of the Australian Research Council Training Centre for Biopharmaceutical Innovation (CBI), University of Queensland. Professor Mahler is a biotechnologist with a focus on R&D of recombinant-DNA derived protein biopharmaceuticals, drug delivery systems and nanomedicines. Professor Mahler has a record of translational research success and engages extensively with industry associated with the biomedical sciences both nationally and internationally.
Research within CBI covers three thematic research areas; discovery of new biopharmaceuticals, engineering cells for production of protein-based biopharmaceuticals and advanced manufacturing for industrial production. A current research interest is at the interface of the life sciences and materials science, using a synthetic biology approach for creating novel therapeutic entities as well as new systems for drug delivery.
Professor Mahler has a strong interest in education and training and was formerly Head of the Chemical and Biological Engineering Plan at the University of Queensland (2010-2016). Other educational initiatives include development of Masters Programs and a Continuing Professional Development program in the area of biopharmaceuticals. The CPD program is available to stakeholders in the industry, both in Australia and internationally.
Availability
- Emeritus Professor Stephen Mahler is:
- Available for supervision
- Media expert
Fields of research
Qualifications
- Doctor of Philosophy, The University of Queensland
Research impacts
Professor Mahler has a strong engagement with industry both nationally and internationally, that through collaborative research has led to some significant translational outcomes including clinical trial of biopharmaceutical drug candidates through to approval. The Australian Research Council Training Centre for Biopharmaceutical Innovation is a consortium of partners including government, the University of Queensland and several industry partners, with a goal of contributing to the transformation of the biopharmaceutical industry. Through the Centre and the CPD Program in Biopharmaceuticals, Professor Mahler continues to work with stakeholders to ensure a vibrant future for the biopharmaceutical industry in Australia.
Works
Search Professor Stephen Mahler’s works on UQ eSpace
1996
Other Outputs
Process for production of glycoproteins
Mahler, S. M., Gebert, C., Chotigeat, W. and Gray, P. P. (1996). Process for production of glycoproteins.
1996
Other Outputs
A system for expression of recombinant proteins
Rajkovic, I., Chin, C. K. and Mahler, S. M. (1996). A system for expression of recombinant proteins. PM4219.
1996
Journal Article
Biological activity and metabolic clearance of recombinant human follicle stimulating hormone produced in Sp2/0 myeloma cells
Chin, C. K., Schofield, P. R., Robertson, D. M., Gray, P. P., Chotigeat, W. and Mahler, S. M. (1996). Biological activity and metabolic clearance of recombinant human follicle stimulating hormone produced in Sp2/0 myeloma cells. Cytotechnology, 21 (2), 171-182. doi: 10.1007/BF02215667
1995
Book Chapter
Downstream processing of monoclonal antibodies produced by cell culture techniques
Mahler, S. M. (1995). Downstream processing of monoclonal antibodies produced by cell culture techniques. Fundamental and applied aspects of animal cell culture. (pp. 197-232) edited by J. P. Barford, C. Harbour, C. P. Marquis, R. Malik, S. Mahler and P. J. Phillips. Singapore: Singapore University Press.
1994
Journal Article
Guiding the Selection of Human-Antibodies From Phage Display Repertoires to a Single Epitope of An Antigen
Jespers, LS, Roberts, A, Mahler, SM, Winter, G and Hoogenboom, HR (1994). Guiding the Selection of Human-Antibodies From Phage Display Repertoires to a Single Epitope of An Antigen. Bio-Technology, 12 (9), 899-903. doi: 10.1038/nbt0994-899
1994
Journal Article
Role of environmental conditions on the expression levels, glycoform pattern and levels of sialyltransferase enzymes for hFSH produced by recombinant CHO cells
Chotigeat, W., Watanapokasin, Y., Mahler, S. M. and Gray, P. P. (1994). Role of environmental conditions on the expression levels, glycoform pattern and levels of sialyltransferase enzymes for hFSH produced by recombinant CHO cells. Cytotechnology, 15 (1-3), 217-221. doi: 10.1007/BF00762396
1994
Conference Publication
Human-Antibodies Derived From Rodent Antibodies Via Epitope Imprinted Selection (eis)
Hoogenboom, HR, Jespers, L, Mahler, S, Roberts, AJ, Chiswell, DJ and Winter, G (1994). Human-Antibodies Derived From Rodent Antibodies Via Epitope Imprinted Selection (eis). NEW YORK: WILEY-LISS.
1994
Conference Publication
Role of Environmental-Conditions On the Expression Levels, Glycoform Pattern and Levels of Sialyltransferase for Hfsh Produced by Recombinant Cho Cells
Chotigeat, W, Watanapokasin, Y, Mahler, S and Gray, PP (1994). Role of Environmental-Conditions On the Expression Levels, Glycoform Pattern and Levels of Sialyltransferase for Hfsh Produced by Recombinant Cho Cells. Cell Culture Engineering IV Conference, San Diego Ca, Mar 07-12, 1994. DORDRECHT: SPRINGER. doi: 10.1007/BF00762396
1993
Journal Article
Isoelectric Charge of Recombinant Human Follicle-Stimulating-Hormone Isoforms Determines Receptor Affinity and Invitro Bioactivity
Cerpapoljak, A, Bishop, LA, Hort, YJ, Chin, Ckh, Dekroon, R, Mahler, SM, Smith, GM, Stuart, MC and Schofield, PR (1993). Isoelectric Charge of Recombinant Human Follicle-Stimulating-Hormone Isoforms Determines Receptor Affinity and Invitro Bioactivity. Endocrinology, 132 (1), 351-356. doi: 10.1210/en.132.1.351
1990
Journal Article
Mammalian cell culture at the University of New South Wales
Gray, P. P., Marsden, W. L., Crowley, J., Gebert, C., Jirasripongpun, K., Lovrecz, G., Mitchell, C. and Mahler, S. M. (1990). Mammalian cell culture at the University of New South Wales. Australian Journal of Biotechnology, 4 (2), 121-134.
1990
Book Chapter
Protein engineering and diagnostic techniques
Mahler, Stephen M. (1990). Protein engineering and diagnostic techniques. Directions in Modern Biotechnology. (pp. 51-71) edited by Pauline M. Doran. Melbourne, VIC, Australia: Hawker Brownlow Education.
1989
Journal Article
Downstream processing of monoclonal antibodies
Gunnersen, J. M., Fowles, L. F., Snelgar, J. M., Mitchell, C. A., Patava, J. V., Osborne, K. J. and Mahler, S. M. (1989). Downstream processing of monoclonal antibodies. Australian Journal of Biotechnology, 3 (1), 69-71.
1988
Journal Article
Desensitization of Adenylate-Cyclase and Cyclic-Amp Flux During the Early Stages of Liver-Regeneration
Mahler, SM and Wilce, PA (1988). Desensitization of Adenylate-Cyclase and Cyclic-Amp Flux During the Early Stages of Liver-Regeneration. Journal of Cellular Physiology, 136 (1), 88-94. doi: 10.1002/jcp.1041360111
1988
Journal Article
Studies On Regenerating Liver and Hepatoma Plasma-Membranes .2. Membrane Fluidity and Enzyme-Activity
Mahler, SM, Wilce, PA and Shanley, BC (1988). Studies On Regenerating Liver and Hepatoma Plasma-Membranes .2. Membrane Fluidity and Enzyme-Activity. International Journal of Biochemistry, 20 (6), 613-619. doi: 10.1016/0020-711X(88)90101-2
1988
Journal Article
Studies On Regenerating Liver and Hepatoma Plasma-Membranes .1. Lipid and Protein-Composition
Mahler, SM, Wilce, PA and Shanley, BC (1988). Studies On Regenerating Liver and Hepatoma Plasma-Membranes .1. Lipid and Protein-Composition. International Journal of Biochemistry, 20 (6), 605-&. doi: 10.1016/0020-711X(88)90100-0
1986
Conference Publication
Comparative-Studies On Plasma-Membrane Isolated From Liver, Hepatoma and Regenerating Liver
Mahler, S, Wilce, PA and Shanley, BC (1986). Comparative-Studies On Plasma-Membrane Isolated From Liver, Hepatoma and Regenerating Liver. BALGOWLAH: ADIS PRESS AUSTRALASIA P/L.
1984
Conference Publication
Membrane Fluidity in Rat Hepatoma Plasma-Membranes
Mahler, S, Shanley, BC and Wilce, PA (1984). Membrane Fluidity in Rat Hepatoma Plasma-Membranes. CLAYTON: PROC AUST BIOCHEMICAL SOC.
Funding
Past funding
Supervision
Availability
- Emeritus Professor Stephen Mahler is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Biosimilar litigation and market entry
Associate Advisor
Other advisors: Professor Avril Robertson, Dr Lisette Pregelj
-
Doctor Philosophy
Engineering Novel Theranostics for High Grade Glioma Through Site-Specific EphA2 Antibody Modification
Associate Advisor
Other advisors: Dr Christopher Howard, Dr Martina Jones
-
Doctor Philosophy
Engineering Novel Theranostics for High Grade Glioma Through Site-Specific EphA2 Antibody Modification
Associate Advisor
Other advisors: Dr Christopher Howard, Dr Martina Jones
Completed supervision
-
2021
Doctor Philosophy
Characterising murine red blood cell phenotypes: the impact of genetic variants in Klf1 and Casd1
Principal Advisor
Other advisors: Professor Benjamin Schulz
-
2020
Doctor Philosophy
Engineering Chinese Hamster Ovary Cells for Improved Monoclonal Antibody Productivity by Modulating Feedback Regulation of the Secretory Pathway
Principal Advisor
Other advisors: Dr Marianne Gillard, Professor Peter Gray
-
2019
Doctor Philosophy
Isolation and characterisation of antibodies against human and canine EphA2_ targets for comparative studies in brain cancer
Principal Advisor
Other advisors: Dr Martina Jones, Professor Andrew Whittaker, Dr Christopher Howard
-
2018
Doctor Philosophy
Isolation and development of antibodies for active targeting of nanocells for cancer therapy
Principal Advisor
Other advisors: Dr Martina Jones, Dr Christopher Howard
-
2017
Master Philosophy
Development of anti-PEG bispecific antibodies for targeting PEGylated nanoparticles to tumour cells
Principal Advisor
Other advisors: Dr Christopher Howard
-
2017
Doctor Philosophy
Development and Application of Novel Biosensor Technologies
Principal Advisor
Other advisors: Dr Martina Jones, Dr Christopher Howard
-
2015
Doctor Philosophy
Beyond antibodies: development of a novel molecular scaffold based on human Chaperonin 10
Principal Advisor
-
2015
Doctor Philosophy
Engineering bispecific antibodies for targeted delivery of cytotoxin-loaded nanoparticles to tumour cells
Principal Advisor
Other advisors: Dr Martina Jones
-
2015
Doctor Philosophy
Antibody Discovery for Development of a Serotyping Dengue Virus NS1 Capture Assay
Principal Advisor
Other advisors: Dr Martina Jones
-
2015
Doctor Philosophy
Design, Assembly and Characterisation of a Multifunctional, Self-Assembled Nanoparticle incorporating Antibody Fragments
Principal Advisor
Other advisors: Dr Martina Jones, Professor Kristofer Thurecht
-
2024
Doctor Philosophy
Development of Antibody Delivery Systems Against Intracellular Targets
Associate Advisor
Other advisors: Dr Christopher Howard
-
2023
Doctor Philosophy
Discovery and Development of a Novel Human Glypican-1 Monoclonal Antibody for Targeting Solid Cancers
Associate Advisor
Other advisors: Dr Martina Jones, Dr Christopher Howard
-
2022
Doctor Philosophy
Dielectric spectroscopy and significance of blood analytes in the microwave and millimetre-wave bands
Associate Advisor
Other advisors: Professor Amin Abbosh
-
2022
Doctor Philosophy
Development of monoclonal antibodies against human neutrophil antigen 3 (HNA-3)
Associate Advisor
Other advisors: Dr Martina Jones
-
2022
Doctor Philosophy
Investigating monoclonal antibody targets on P. falciparum and red blood cell antigens using experimental mouse model and phage display technology
Associate Advisor
Other advisors: Dr Martina Jones
-
2021
Doctor Philosophy
An investigation of human antibodies to blood group antigens for the management of haemolytic disease of the fetus and newborn
Associate Advisor
Other advisors: Dr Martina Jones
-
2021
Doctor Philosophy
The Isolation and Characterisation of Novel Antibodies Against the Murine Beta Common Receptor Using Two Methods of Phage Display Biopanning
Associate Advisor
Other advisors: Dr Martina Jones
-
2021
Doctor Philosophy
Structural Studies of MNS Glycophorins to Guide the Discovery of Monoclonal Antibodies
Associate Advisor
Other advisors: Dr Martina Jones
-
2020
Doctor Philosophy
Development of novel bioconjugation strategies for creating cancer-targeting nanomaterials
Associate Advisor
Other advisors: Dr Martina Jones, Dr Christopher Howard
-
2018
Doctor Philosophy
Engineering lipid-coated calcium phosphate nanoparticles with multiple ligands to amplify in vivo tumor target delivery
Associate Advisor
Other advisors: Dr Christopher Howard
-
2015
Doctor Philosophy
Development of monoclonal antibodies as tools for analysis of PTPRJ function.
Associate Advisor
Other advisors: Dr Martina Jones
-
2014
Doctor Philosophy
Surface interactions and biochemical responses to bacterial attachment in bioleaching of minerals
Associate Advisor
Other advisors: Professor Anh Nguyen
Media
Enquiries
Contact Emeritus Professor Stephen Mahler directly for media enquiries about:
- Antibodies
- Biologic medicines
- Pharmaceuticals
Need help?
For help with finding experts, story ideas and media enquiries, contact our Media team: